Arrhenoblastoma associated with adrenal androgenic hyperfunction.
D015068:17-Ketosteroids / Q000652:urine; D000308:Adrenocortical Hyperfunction / Q000150:complications*; D000328:Adult; D000568:Amenorrhea / Q000209:etiology; D000728:Androgens / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D000735:Androstenedione / Q000097:blood; D003276:Contraceptives, Oral / Q000494:pharmacology; D003687:Dehydroepiandrosterone / Q000097:blood; D003864:Depression, Chemical; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000150:complications; D007247:Infertility, Female / Q000209:etiology; D008656:Mestranol / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use; D010049:Ovarian Diseases / Q000150:complications; D010051:Ovarian Neoplasms / Q000150:complications* / Q000473:pathology / Q000601:surgery; D018310:Sertoli-Leydig Cell Tumor / Q000150:complications* / Q000473:pathology / Q000601:surgery; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D000728:Androgens; D003276:Contraceptives, Oral; D004338:Drug Combinations; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D003907:Dexamethasone; D009641:Norethynodrel; D008656:Mestranol